Clinical facial composite tissue allotransplantation: A review of the first four global experiences and future implications

Plastic and Reconstructive Surgery

Volumn 125, Issue 2, 2010, Pages 538-546

  Hui Chou, Helen G ^a,b,c   Nam, Arthur J ^a,b,c   Rodriguez, Eduardo D ^a,b,c  

^a R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

^b Hopkins University   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ACUTE DISEASE; ALLOTRANSPLANTATION; CONVALESCENCE; FACIAL TRANSPLANTATION; GRAFT REJECTION; HUMAN; INTERNATIONAL COOPERATION; POSTOPERATIVE COMPLICATION; REVIEW; TREATMENT OUTCOME;

ACUTE DISEASE; FACIAL TRANSPLANTATION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERNATIONALITY; POSTOPERATIVE COMPLICATIONS; RECOVERY OF FUNCTION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 76949084151     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181c722a8     Document Type: Review

References (31)

1. Devauchelle B, Badet L, Lengele B, et al. First human face allograft: Early report. Lancet 2006;368:203-209.
2. Guo S, Han Y, Zhang X, et al. Human facial allotransplantation: A 2-year follow-up study. Lancet 2008;372:631-638.
3. Lantieri L, Meningaud JP, Grimbert P, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: A 1-year follow-up study. Lancet 2008;372:639-645.
4. Dubernard JM, Lengele B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med. 2007;357:2451-2460.
5. Meningaud JP, Paraskevas A, Ingallina F, Bouhana E, Lantieri L. Face transplant graft procurement: A preclinical and clinical study. Plast Reconstr Surg. 2008;122:1383-1389.
6. Kanitakis J, Badet L, Petruzzo P, et al. Clinicopathologic monitoring of the skin and oral mucosa of the first human face allograft: Report on the first eight months. Transplantation 2006;82:1610-1615.
7. Langstein HN, Robb GL. Lip and perioral reconstruction. Clin Plast Surg. 2005;32:431-445.
8. Spinelli HM, Jelks GW. Periocular reconstruction: A systematic approach. Plast Reconstr Surg. 1993;91:1017-1024; discussion 1025-1026.
9. Horch RE, Jeschke MG, Spilker G, Herndon DN, Kopp J. Treatment of second degree facial burns with allografts: Preliminary results. Burns 2005;31:597-602.
10. Dvorak HF, Mihm MC Jr, Dvorak AM, Barnes BA, Manseau EJ, Galli SJ. Rejection of first-set skin allografts in man: The microvasculature is the critical target of the immune response. J Exp Med. 1979;150:322-337.
11. Wendt JR, Ulich T, Rao PN. Long-term survival of human skin allografts in patients with immunosuppression. Plast Reconstr Surg. 2004;113:1347-1354.
12. Wendt JR, Ulich TR, Ruzics EP, Hostetler JR. Indefinite survival of human skin allografts in patients with long-term immunosuppression. Ann Plast Surg. 1994;32:411-417.
13. Tzakis AG, Reyes J, Zeevi A, et al. Early tolerance in pediatric liver allograft recipients. J Pediatr Surg. 1994;29:754-756.
14. Mineo D, Ricordi C. Chimerism and liver transplant tolerance. J Hepatol. 2008;49:478-480.
15. Starzl TE. Acquired immunologic tolerance: With particular reference to transplantation. Immunol Res. 2007;38:6-41.
16. Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant. 2004;4:1089-1096.
17. Tanabe K, Takahashi K, Sonda K, et al. ABO-incompatible living kidney donor transplantation: Results and immunological aspects. Transplant Proc. 1995;27:1020-1023.
18. Tanabe K, Tokumoto T, Ishikawa N, et al. ABO-incompatible living donor kidney transplantation under tacrolimus immunosuppression. Transplant Proc. 2000;32:1711-1713.
19. Hewitt CW, Black KS, Henson LE, Achauer BM, Nguyen JH. Lymphocyte chimerism in a full allogeneic composite tissue (rat-limb) allograft model prolonged with cyclosporine. Transplant Proc. 1988;20:272-278.
20. Dellon ES, Mourey R, Dellon AL. Human pressure perception values for constant and moving one- and two-point discrimination. Plast Reconstr Surg. 1992;90:112-117.
21. Tassler PL, Dellon AL. Correlation of measurements of pressure perception using the pressure-specified sensory device with electrodiagnostic testing. J Occup Environ Med. 1995;37:862-866.
22. Coert JH, Meek MF, Gibeault D, Dellon AL. Documentation of posttraumatic nerve compression in patients with normal electrodiagnostic studies. J Trauma 2004;56:339-344.
23. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
24. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
25. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-483.
26. VanSwearingen JM, Brach JS. The Facial Disability Index: Reliability and validity of a disability assessment instrument for disorders of the facial neuromuscular system. Phys Ther. 1996;76:1288-1298; discussion 1298-1300.
27. Ruiz P, Garcia M, Pappas P, et al. Mucosal vascular alterations in isolated small-bowel allografts: Relationship to humoral sensitization. Am J Transplant. 2003;3:43-49.
28. Ruiz P, Garcia M, Pappas P, et al. Mucosal vascular alterations in the early posttransplant period of small bowel allograft recipients may reflect humoral-based allograft rejection. Transplant Proc. 2002;34:869-871.
29. Abu-Elmagd KM, Costa G, Bond GJ, et al. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance. Transpl Int. 2009; 22:96-109.
30. Fryer JP. The current status of intestinal transplantation. Curr Opin Organ Transplant. 2008;13:266-272.
31. Cendales LC, Kanitakis J, Schneeberger S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant. 2008;8:1396-1400.